Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities of continuing operations:
Net income (loss)	$ (566,221)	$ (965,686)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount	49,450	17,347
Common stock issued in exchange for fees and services	40,000
Derivative expense	129,961
(Gain) Loss on Change in value of derivative liabilities	(104,386)	292,536
(Gain) loss on issuance of stock		24,000
Changes in operating assets and liabilities:
Accrued liabilities	345,438	576,109
Related party payables	4,350	25
Net cash provided by (used in) operating activities	(101,408)	(55,669)
INVESTING ACTIVITIES
Net cash provided by (used in) investing activities
FINANCING ACTIVITIES
Proceeds from issuance of common stock	20,000	38,000
Proceeds from issuance of convertible notes	81,500	17,500
Net cash provided by (used in) financing activities	101,500	55,500
Net increase (decrease) in cash and cash equivalents	92	(169)
Cash and cash equivalents at beginning of period	19	188
Cash and cash equivalents at end of period	111	19
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued to reduce convertible and promissory notes payable	9,930
Series E preferred stock issued in lieu of cash for accrued officer compensation	17,500
Series E preferred stock issued in exchange for conversion of promissory note and accrued interest	18,398
Series E preferred stock issued in exchange for shares of common stock		$ 96,000